Sichuan Deebio Pharmaceutical Co., Ltd accepted the official GMP compliance inspection from Japan PMDA from 8.25 to 8.26 in 2022. The GMP audit team consisted of two auditors led by experienced veteran experts and carried out a two-day remo…

Deebio's Global Bio-enzyme Journey: 27 Years, 30 Countries and RegionsRead more, please click this linkhttps://www.drugpatentwatch.com/blog/drug-patent-news/?rkey=20210831CN91584&filter=20229

Jul 07, 2021 (AB Digital via COMTEX) -- Recently, another piece of good news comes from the Chinese bio-enzyme API industry. The first batch of thyroid API produced by Sichuan Deebio Pharmaceutical Co., Ltd. has been sent to the United Stat…